Education
About Us
Working with TipRanks
Follow Us
Bio-Gene Technology Ltd. (AU:BGT)
ASX:BGT
Total Valuation
Bio-Gene Technology Ltd. has a market cap or net worth of AU$5.03M. The enterprise value is ―.
Market CapAU$5.03M
Enterprise Value―
Share Statistics
Bio-Gene Technology Ltd. has 201,361,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding201,361,570
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bio-Gene Technology Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Bio-Gene Technology Ltd. is ―. Bio-Gene Technology Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio16.38
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Bio-Gene Technology Ltd. had revenue of 18.32K and earned -2.41M in profits. Earnings per share was -0.01.
Revenue18.32K
Gross Profit-301.45K
Operating Income-3.06M
Pretax Income-3.01M
Net Income-2.41M
EBITDA-2.97M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.75M and capital expenditures -5.70K, giving a free cash flow of -2.76M billion.
Operating Cash Flow-2.75M
Free Cash Flow-2.76M
Free Cash Flow per Share-0.01
Dividends & Yields
Bio-Gene Technology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change-75.00%
50-Day Moving Average0.03
200-Day Moving Average0.04
Relative Strength Index (RSI)28.13
Average Volume (3m)104.45K
Important Dates
Bio-Gene Technology Ltd. upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.
Last Earnings DateFeb 27, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend Date―
Financial Position
Bio-Gene Technology Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Bio-Gene Technology Ltd. has paid -604.19K in taxes.
Income Tax-604.19K
Effective Tax Rate―
Enterprise Valuation
Bio-Gene Technology Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Bio-Gene Technology Ltd. has AU$2.21M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of -AU$2.21M billion.
Cash & Marketable SecuritiesAU$2.21M
Total DebtAU$0.00
Net Cash-AU$2.21M
Net Cash Per Share-AU$0.01
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Bio-Gene Technology Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―